The Essential Role of TAp73 in Bortezomib-induced Apoptosis in P53-deficient Colorectal Cancer Cells

Overview

Journal Sci Rep

Specialty Science

Date 2017 Jul 16

PMID 28710427

Citations 16

Authors

Yasamin Dabiri

Sara Kalman

Clara-Marie Gurth

Jee Young Kim

Viola Mayer

Xinlai Cheng

Affiliations

Soon will be listed here.

Abstract

Mutations in the tumor suppressor p53 are among the most highly occurring events in colorectal cancer (CRC). Such mutations have been shown to influence the sensitivity of cancer cells to chemotherapeutic agents. However their impact on the efficacy of the proteasomal inhibitor bortezomib remains controversial. We thus re-evaluated the toxicity of bortezomib in the CRC cell lines HCT116 wt (wild-type) and its p53-/- clone. Transient resistance to bortezomib treatment was observed in p53-null cells that was later accompanied by an increase in levels and nuclear translocation of TAp73, an isoform of the p53-homologue p73, as well as induction of apoptosis. Knockdown of p73 in p53-/- cells using CRISPR/Cas9 significantly prolonged the duration of resistance. Moreover, similar results were observed in HT-29 cells carrying mutated p53, but not human fibroblasts with expression of functional p53. Thus, our results clearly demonstrated that TAp73 served as a substitute for p53 in bortezomib-induced apoptosis in p53-deficient or mutated cells, implicating that TAp73 could be a potential therapeutic target for treatment of CRCs, in particular those lacking functional p53.

Citing Articles

Reduced Levels of Misfolded and Aggregated Mutant p53 by Proteostatic Activation.

Naus E, Derweduwe M, Lampi Y, Claeys A, Pauwels J, Langenberg T Cells. 2023; 12(6).

PMID: 36980299 PMC: 10047295. DOI: 10.3390/cells12060960.

P63 and P73 Activation in Cancers with p53 Mutation.

Cai B, Hsu Y, Yeh F, Lin Y, Lu R, Yu S Biomedicines. 2022; 10(7).

PMID: 35884795 PMC: 9313412. DOI: 10.3390/biomedicines10071490.

p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies.

Horvat A, Tadijan A, Vlasic I, Slade N Cancers (Basel). 2021; 13(12).

PMID: 34207603 PMC: 8227208. DOI: 10.3390/cancers13122885.

The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing.

Zawacka-Pankau J Cancers (Basel). 2020; 12(9).

PMID: 32971841 PMC: 7563196. DOI: 10.3390/cancers12092717.

Endoplasmic reticulum stress triggers delanzomib-induced apoptosis in HCC cells through the PERK/eIF2α/ATF4/CHOP pathway.

Li J, Zhuo J, Zhou W, Hong J, Chen R, Xie H Am J Transl Res. 2020; 12(6):2875-2889.

PMID: 32655816 PMC: 7344101.

References

Vayssade M, Haddada H, Faridoni-Laurens L, Tourpin S, Valent A, Benard J . P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Int J Cancer. 2005; 116(6):860-9. DOI: 10.1002/ijc.21033. View

Kartasheva N, Contente A, Roth J, Dobbelstein M . p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Oncogene. 2002; 21(31):4715-27. DOI: 10.1038/sj.onc.1205584. View

Melino G, De Laurenzi V, Vousden K . p73: Friend or foe in tumorigenesis. Nat Rev Cancer. 2002; 2(8):605-15. DOI: 10.1038/nrc861. View

Lenz H . Clinical update: proteasome inhibitors in solid tumors. Cancer Treat Rev. 2003; 29 Suppl 1:41-8. DOI: 10.1016/s0305-7372(03)00082-3. View

Yang A, McKeon F . P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol. 2001; 1(3):199-207. DOI: 10.1038/35043127. View

Roger L, Jullien L, Gire V, Roux P . Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. J Cell Sci. 2010; 123(Pt 8):1295-305. DOI: 10.1242/jcs.061002. View

Cheng X, Dimou E, Alborzinia H, Wenke F, Gohring A, Reuter S . Identification of 2-[4-[(4-Methoxyphenyl)methoxy]-phenyl]acetonitrile and Derivatives as Potent Oct3/4 Inducers. J Med Chem. 2015; 58(12):4976-83. DOI: 10.1021/acs.jmedchem.5b00144. View

Jallepalli P, Lengauer C, Vogelstein B, Bunz F . The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J Biol Chem. 2003; 278(23):20475-9. DOI: 10.1074/jbc.M213159200. View

Vaziri S, Grabowski D, Hill J, Rybicki L, Burk R, Bukowski R . Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independent. Anticancer Res. 2009; 29(8):2961-9. PMC: 4141551. View

10.

Strauss S, Higginbottom K, Juliger S, Maharaj L, Allen P, Schenkein D . The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines. Cancer Res. 2007; 67(6):2783-90. DOI: 10.1158/0008-5472.CAN-06-3254. View

11.

Yu J, Zhang L, Hwang P, Kinzler K, Vogelstein B . PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell. 2001; 7(3):673-82. DOI: 10.1016/s1097-2765(01)00213-1. View

12.

Han S, Semba S, Abe T, Makino N, Furukawa T, Fukushige S . Infrequent somatic mutations of the p73 gene in various human cancers. Eur J Surg Oncol. 1999; 25(2):194-8. DOI: 10.1053/ejso.1998.0626. View

13.

Kurita T, Cunha G, Robboy S, Mills A, Medina R . Differential expression of p63 isoforms in female reproductive organs. Mech Dev. 2005; 122(9):1043-55. DOI: 10.1016/j.mod.2005.04.008. View

14.

Williams S, McConkey D . The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells. Cancer Res. 2003; 63(21):7338-44. View

15.

Liu Y, Zhang X, Han C, Wan G, Huang X, Ivan C . TP53 loss creates therapeutic vulnerability in colorectal cancer. Nature. 2015; 520(7549):697-701. PMC: 4417759. DOI: 10.1038/nature14418. View

16.

MacLaren A, Chapman R, Wyllie A, Watson C . p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ. 2001; 8(3):210-8. DOI: 10.1038/sj.cdd.4400801. View

17.

Cheng X, Alborzinia H, Merz K, Steinbeisser H, Mrowka R, Scholl C . Indirubin derivatives modulate TGFβ/BMP signaling at different levels and trigger ubiquitin-mediated depletion of nonactivated R-Smads. Chem Biol. 2012; 19(11):1423-36. DOI: 10.1016/j.chembiol.2012.09.008. View

18.

Cheng X, Holenya P, Can S, Alborzinia H, Rubbiani R, Ott I . A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells. Mol Cancer. 2014; 13:221. PMC: 4190468. DOI: 10.1186/1476-4598-13-221. View

19.

Montero J, Dutta C, van Bodegom D, Weinstock D, Letai A . p53 regulates a non-apoptotic death induced by ROS. Cell Death Differ. 2013; 20(11):1465-74. PMC: 3792438. DOI: 10.1038/cdd.2013.52. View

20.

Cheng X, Merz K, Vatter S, Christ J, Wolfl S, Eisenbrand G . 7,7'-Diazaindirubin--a small molecule inhibitor of casein kinase 2 in vitro and in cells. Bioorg Med Chem. 2013; 22(1):247-55. DOI: 10.1016/j.bmc.2013.11.031. View